Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria

Diabetes Care. 2002 Jul;25(7):1254-5. doi: 10.2337/diacare.25.7.1254.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Albuminuria / drug therapy*
  • Antihypertensive Agents / therapeutic use*
  • C-Reactive Protein / antagonists & inhibitors
  • C-Reactive Protein / drug effects
  • C-Reactive Protein / metabolism*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Nephropathies / drug therapy
  • Female
  • Humans
  • Losartan / therapeutic use*
  • Male
  • Reference Values

Substances

  • Antihypertensive Agents
  • C-Reactive Protein
  • Losartan